Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148943 Novel tachykinin-like polypeptides and use thereof
08/07/2003US20030148937 Methods and compositions for use in spliceosome mediated RNA trans-splicing
08/07/2003US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders
08/07/2003US20030148929 Polypeptide comprises diaminobutyric acid for safe delivery to cells
08/07/2003US20030148928 Enzymatic nucleic acid peptide conjugates
08/07/2003US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents
08/07/2003US20030148544 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof
08/07/2003US20030148525 Reaction is terminated where absent free nucleotide would be inserted in sequence; mass spectrometry
08/07/2003US20030148523 Transporting material through membranes of cells in trehalose culture; genetic engineering
08/07/2003US20030148522 Equine infectious anemia viral plasmid for transfection of heterologous genes into mammalian cells
08/07/2003US20030148520 Replication-competent adenovirus vector comprising first and second genes co-transcribed as a single mRNA wherein the first and the second genes are under transcriptional control of a heterologous, target cell-specific transcriptional
08/07/2003US20030148519 Intracellular expression and delivery of siRNAs in mammalian cells
08/07/2003US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells
08/07/2003US20030148514 Human embryonic germ cell line and methods of use
08/07/2003US20030148509 Retrovirus isolated from humans
08/07/2003US20030148508 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
08/07/2003US20030148507 RNA interference mediated inhibition of prostaglandin D2 receptor (PTGDR) and prostaglandin D2 synthetase (PTGDS) gene expression using short interfering RNA
08/07/2003US20030148506 Preparing genetically engineered parvoviral particles in insect cells; gene therapy
08/07/2003US20030148503 Reaction system for thermal cycling
08/07/2003US20030148500 Transcription factor
08/07/2003US20030148495 Useful mutations of bacterial alkaline protease
08/07/2003US20030148494 Nucleotide sequences coding methylomonas pyrophosphate dependent phosphofructokinase (PDP) for preparing heterpolysaccharide; food thickeners; supension agents for pesticides and paints
08/07/2003US20030148493 Sialidase and recombinant cell lines
08/07/2003US20030148491 Comprises receptor-like protein tyrosine phosphatase polypeptides (DEP-1) for use as antiinflammatory/anticarcinogenic agents
08/07/2003US20030148489 Plant lyase protein for producing taste products, drugs, pigments and hop secondary metabolites; alcoholic beverages
08/07/2003US20030148484 Comprises genetically engineered growth factor precursor for use as genetic vaccine; immunoassays
08/07/2003US20030148482 Method for producing xylitol
08/07/2003US20030148480 Method for producing methacrylic acid acrylic acid with a combination of enzyme catalysts
08/07/2003US20030148479 Biosynthesis of isopentenyl pyrophosphate
08/07/2003US20030148475 Mutant N-acetylglutamate synthase and method for L-arginine production
08/07/2003US20030148474 Modified glutamine synthetase expressed in Escherichia for biosynthesis of glutamine, arginine, tryptophan, histidine and glutamate; for assimilation of ammonia
08/07/2003US20030148472 Comprises nucleotide sequences coding hydantoinase/hydrolases for producing pharmaceuticals, chemical industrial products and food
08/07/2003US20030148470 Propargylethoxyamino nucleotides
08/07/2003US20030148469 Combinatorial polyketide libraries produced using a modular PKS gene cluster as scaffold
08/07/2003US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases
08/07/2003US20030148464 Comprises nucleotides sequences contained in expression vector which code mutant hydrolase with reduced activity and additional heterologous polypeptides
08/07/2003US20030148461 Comprises genetically engineered subtilisin regulatory sequence for increasing expression of heterologous proteins such as proteases, lipases and amylases in bioreactors/trangenic cells
08/07/2003US20030148459 Comprises nucleotide sequences coding glycosyltransferases/acyltransferases for lipid A biosynthesis and ganglioside mimetics; prevention pathogen infections
08/07/2003US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003US20030148456 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/07/2003US20030148453 Production and secretion of proteins of bacterial origin in filamentous fungi
08/07/2003US20030148452 Producing polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first nucleic acid sequence encoding the polypeptide operably linked
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148445 Comprises tumor necrosis factor ligand (TALL-1) and transmembrane polypeptide expressed in monocytes/macrophage for treatment of autoimmune diseases; antiproliferative agents
08/07/2003US20030148444 Sodium-independent small neutral amino acid transporters transporting L- and D-amino acids and genes thereof
08/07/2003US20030148443 Epoxide hydrolases, nucleic acids encoding them and methods of making and using them
08/07/2003US20030148441 Method for preparing polypeptide variants
08/07/2003US20030148440 Preparing hydroxynitrilase for generation of cyanohydrins; disease resistant plants
08/07/2003US20030148439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148436 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148434 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148432 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148430 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148426 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148425 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148423 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148422 Method for diversifying the chemical composition of proteins produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases
08/07/2003US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003US20030148417 Comprises genetically engineered aspartic protease for use in food processing; improving cocoa flavoring; odors
08/07/2003US20030148416 Isoprenoid production
08/07/2003US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors
08/07/2003US20030148408 Compositions and methods for the diagnosis and treatment of tumor
08/07/2003US20030148403 Using fluorescence for quantitative analysis of ligand/receptor binding activity; bioreactors
08/07/2003US20030148398 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/07/2003US20030148397 Identifying bactericidal or microbiocidal amino acid sequences
08/07/2003US20030148396 Comprises p65 binding polypeptide (RAI) for diagnosis and treatment of adult respiratory distress syndrome, asthma, allograft rejection, cancer and inflammatory/autoimmune/vasoreconstrictive diseases
08/07/2003US20030148394 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058, or 6351 molecules
08/07/2003US20030148392 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening
08/07/2003US20030148390 Dose response-based methods for identifying receptors having alterations in signaling
08/07/2003US20030148389 Schizophrenia related gene and protein
08/07/2003US20030148388 Patched genes and uses related thereto
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
08/07/2003US20030148378 Phosphodiesterase 10
08/07/2003US20030148372 Comprises nucleotide sequence repertoire coding antibody polypeptides; anticarcinogenic/antiinflammatory/antiarthritic agents; antiallergens; bactericides; viricides
08/07/2003US20030148369 Novel uses of mammalian CCR8 receptors and related reagents
08/07/2003US20030148368 Comprises amino acid sequences for improving crop yields; pesticides; herbicides; drug screening; disease resistance plants
08/07/2003US20030148366 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins,and uses thereof
08/07/2003US20030148361 Reagent for detecting biopolymer and method for detecting biopolymer
08/07/2003US20030148356 Amyloid precursor protein (APP); secretases
08/07/2003US20030148355 Gene expression levels indicate sleep disorders
08/07/2003US20030148353 Method for in vitro molecular evolution of protein function
08/07/2003US20030148352 Reverse transcriptase transcribes RNA into single-stranded DNA which binds chromosomes forming triplex that mediates recombination; restriction enzymes; gene therapy; antisense agents
08/07/2003US20030148348 Self-replicating RNA molecule from hepatitis C virus
08/07/2003US20030148346 Comprises Staphylococcus aureus virulence genes which target bactericides in assay; drug screening; vaccines
08/07/2003US20030148344 Annealing primer and single-stranded template, combining with polymerase, then adding nucleotide triphosphate; optical fibers; semiconductors; eliminates cloning
08/07/2003US20030148340 Method and kits for preparing multicomponent nucleic acid constructs
08/07/2003US20030148336 Polymorphic marker that can be used to assess the efficacy of interferon therapy
08/07/2003US20030148333 HCV anti-core monoclonal antibodies
08/07/2003US20030148332 Adaptive baseline algorithm for quantitative PCR